Re-emergence of dengue virus 3 genotype III in Cabo Verde, 2023

Menilita Dos Santos,Idrissa Dieng, Isaias Baptista Fernandes Varela, Kevin Sanders Da Rosa Carvalho, Domingos Dias Texeira, Ullardina Furtado, Liliane Hungria, Leticia Souza, Leidiza Tavares,Aliou Barry, Cheikh Tallo,Samba Niang Sagne,Ousmane Faye,Ndongo Dia,Cheikh Loucoubar,Oumar Faye,Amadou Alpha Sall, Boubacar Diallo,Moussa Moise Diagne, Maria Da Luz Lima,Abdourahmane Sow

medrxiv(2024)

引用 0|浏览2
暂无评分
摘要
We characterized 11 autochthonous dengue virus serotype 3 cases from Santiago and Fogo islands (Cabo Verde), 14 years after Cabo Verde's latest noticed DENV outbreak involving this serotype. Identified viruses are closely related to Asian strains and falling into a clade distinct from known circulating West African DENV-3/Genotype III isolates. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was funded by Bill and Melinda Gates Foundation under grant (INV-050589) and the Africa Pathogen Genomics Initiative (CARES grant 4306-22-EIPHLSS-GENOMICS). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Cabo Verdien National Ethical Committee of the Ministry of Health approved the surveillance protocol which lead to the obtention of human sera as less than minimal risk research, and written consent were not required. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要